{
    "organizations": [],
    "uuid": "ef77b71e56ecaf18aefb1cf7b8640f74b300f7d8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-brightpath-biotherapeutics-says-ex/brief-brightpath-biotherapeutics-says-exercise-of-options-idUSL4N1P62AY",
    "ord_in_thread": 0,
    "title": "BRIEF-BrightPath Biotherapeutics says exercise of options",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 11 (Reuters) - BrightPath Biotherapeutics Co Ltd :\n* Says 6,500 units of its 12th series options were exercised to 650,000 shares of its common stock from Jan. 10 to Jan. 11\nSource text in Japanese: goo.gl/vgWBcX\nFurther company coverage: (Beijing Headline News)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-01-11T14:15:00.000+02:00",
    "crawled": "2018-01-12T18:37:20.017+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "brightpath",
        "biotherapeutics",
        "co",
        "ltd",
        "say",
        "unit",
        "12th",
        "series",
        "option",
        "exercised",
        "share",
        "common",
        "stock",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}